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Hypertension is a cardiovascular risk factor present in over twothirds of people over age 60 in North America; elevated blood pressure correlates with increased risk of heart attack, stroke and progression to heart and kidney failure. Current therapies are insufficient to control blood pressure in almost half of these patients 1, 2 . The mineralocorticoid receptor (MR), acting in the kidney, is known to regulate blood pressure through aldosterone binding and stimulation of sodium retention 3 . However, recent studies support the concept that the MR also has extrarenal actions [4] [5] [6] [7] and that defects in sodium handling alone do not fully explain the development of hypertension and associated cardiovascular mortality 8, 9 . We and others have identified functional MR in human vascular smooth muscle cells (SMCs) 10, 11 , suggesting that vascular MR might directly regulate blood pressure. Here we show that mice with SMCspecific deficiency of the MR have decreased blood pressure as they age without defects in renal sodium handling or vascular structure. Aged mice lacking MR in SMCs (SMC-MR) have reduced vascular myogenic tone, agonist-dependent contraction and expression and activity of L-type calcium channels. Moreover, SMC-MR contributes to angiotensin IIinduced vascular oxidative stress, vascular contraction and hypertension. This study identifies a new role for vascular MR in blood pressure control and in vascular aging and supports the emerging hypothesis that vascular tone contributes directly to systemic blood pressure.
The renin-angiotensin-aldosterone system is a hormonal cascade with a well-recognized role in blood pressure regulation. Angiotensin II (AngII) acts via the angiotensin type 1 receptor (AT1R) on vascular cells to cause vasoconstriction and on adrenal cells to cause release of the hormone aldosterone that activates renal MR to modulate sodium balance 12 . Mice deficient in the MR in all tissues die in the neonatal period from salt wasting, which is consistent with the known role of the MR in regulating vascular volume 13, 14 . However, mice with renal tubule-specific MR deficiency survive unless challenged with low-salt conditions 15, 16 , supporting the concept that loss of extra-renal MR contributes to the hypotension and mortality associated with complete MR deficiency. MR antagonists prevent activation of the MR 11, 12 and decrease blood pressure and cardiovascular mortality [17] [18] [19] . A recent analysis of MR antagonist trials for the treatment of hypertension concluded that a component of the blood pressure-lowering effect of MR antagonism can be distinguished from effects on urinary electrolyte excretion, supporting the relevance of renal-independent regulation of blood pressure by the MR in humans 6, 20 . Mice overexpressing the MR in endothelial cells have high blood pressure 7 , but the role of endogenous vascular MR in the regulation of blood pressure has not been explored.
We generated mice lacking MR specifically in SMCs by first creating mice with a loxP-flanked MR (MR f/f ) allele and then breeding these mice with mice containing the SMA-Cre-ER T2 transgene, in which the smooth muscle actin promoter drives expression of the tamoxifeninducible Cre-ER T2 recombinase 21 (Supplementary Fig. 1a ). Comparisons were made between tamoxifen-treated MR f/f /SMA-Cre-ER T2 -positive (Cre + ) mice and tamoxifen-treated MR f/f /SMA-Cre-ER T2 -negative (Cre − ) littermate controls. After treatment of Cre + mice with tamoxifen, the gene encoding MR (Nr3c2) remained intact in tissues lacking substantial SMC populations ( Fig. 1a) , but vascular SMCs showed near-complete excision of Nr3c2 and loss of MR mRNA expression ( Fig. 1b,c and Supplementary Fig. 1) ; aortic mRNA expression of angiotensin receptors (AT1a, AT1b and AT2) was not altered (data not shown). In addition, we observed no alterations in feeding or growth in Cre + mice compared to Cre − littermate controls ( Supplementary Table 1 and data not shown).
Telemetric blood pressure monitoring revealed lower blood pressure in male Cre + mice compared to Cre − littermates ( Fig. 1d) . This blood pressure difference increased with age, becoming significant by age 7 months. We assessed contraction and relaxation of mesenteric resistance arteries (MRAs) in adult (3-4 months old) and aged (>9 months old) mice. Vessels from Cre + adult mice showed a modest increase in contraction to phenylephrine and enhanced endothelialdependent vasodilatation compared to vessels from Cre − controls, consistent with the lack of a significant difference in the blood pressure Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors of adult Cre − and Cre + mice ( Fig. 1e and Supplementary Fig. 2 ). MRAs from aged Cre − mice showed significantly augmented contraction in response to KCl or the thromboxane receptor agonist U46619 compared to MRAs from Cre − adult mice ( Fig. 1e) . This age-dependent increase in contraction response was lost in aged Cre + littermates ( Fig. 1e) and was associated with a modest decrease in endothelial cell-independent vasodilatation in MRAs from aged Cre + compared to aged Cre − mice ( Supplementary Fig. 2 ). Phenylephrine-induced contraction increased with age regardless of genotype, indicating that not all age-dependent increases in contractile responses are lost in this model (Fig. 1e) . These data support a direct role for SMC-MR in blood pressure regulation by modulating the intrinsic vascular function of resistance vessels, particularly with aging.
As the MR contributes to blood pressure control by modulating renal sodium handling 3 , we investigated the salt sensitivity of blood pressure in Cre + and Cre − mice. In adult mice, there was no blood pressure difference between genotypes, regardless of dietary sodium intake ( Fig. 2a) . The lower blood pressure of aged Cre + mice compared to aged Cre − mice was maintained under both high-and low-sodium conditions ( Fig. 2b) and throughout the diurnal cycle ( Supplementary Fig. 3 ). We observed no difference in serum or urine electrolytes or in serum aldosterone levels between Cre + and Cre − mice (Supplementary Table 1 ). Treatment of mice by providing them with 1% NaCl drinking water together with infusion of aldosterone significantly increased blood pressure to similar levels in adult and aged mice, and these responses were independent of genotype ( Fig. 2c,d) . 
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On a low-sodium diet, aged mice showed the expected decrease in urinary sodium excretion and fractional excretion of sodium, regardless of genotype ( Fig. 2e,f) . These results are consistent with intact MR function in the kidney tubules of these mice and support an extrarenal, SMC-MR-dependent mechanism for blood pressure regulation. We next examined the effect of SMC-MR deficiency on vascular structure. Aortic medial area and collagen content increased with age independently of the presence of SMC-MR ( Fig. 3a,b) . In 18-month-old mice, cardiac hypertrophy occurred in Cre − but not Cre + mice (Supplementary Fig. 4) , consistent with the end-organ effects of longstanding exposure to lower blood pressure in the Cre + mice. As resistance vessels are crucial in modulating blood pressure, we examined the structural characteristics of pressurized MRAs from aged mice. Vessels from aged Cre + and Cre − mice had similar passive vessel and lumen diameters and similar values for area, stress, strain, distensibility and stiffness over a range of intraluminal pressures (Fig. 3c,d and Supplementary Table 1 ). However, MRAs from aged Cre + mice developed significantly less spontaneous myogenic tone compared to those from Cre − mice (Fig. 3d) . These data support the hypothesis that SMC-MR contributes to vascular tone and blood pressure regulation in aged mice independently of vascular structural changes.
Voltage-gated calcium (Ca) channel activation contributes to myogenic tone, whereas large-conductance Ca-activated potassium channels (BKCa) counter-regulate myogenic constriction 22 . As coronary artery BKCa expression is reduced in mice with cardiac-specific aldosterone synthase overexpression 23 , we first examined BKCa activity. Patch-clamp studies of mesenteric SMCs from aged Cre + and Cre − mice revealed no differences in total potassium (K + ) current, the proportion of K + current from BKCa or voltage-activated K + channels, or the response of BKCa to activation with the agonist NS1619 or inhibition with iberiotoxin ( Fig. 3e) . mRNA expression of the BKCa subunits BKCaα1 and BKCaβ1 was not different between aged Cre − and Cre + vessels, but expression of the L-type Ca channel Cav1.2 was significantly lower in Cre + vessels (Fig. 3f) . In addition, the contractile response of MRAs to the L-type Ca channel agonist BayK8644 was significantly lower in vessels from aged Cre + mice compared to those from aged Cre − mice (Fig. 3g) . These data support the concept that npg regulation of L-type Ca channels by SMC-MR underlies age-associated alterations in myogenic tone, agonist-induced contraction and blood pressure. Renin-angiotensin-aldosterone system signaling is recognized to be enhanced in the aging vasculature, contributing to the vascular aging phenotype [24] [25] [26] . Given that we previously demonstrated direct AT1R-dependent activation of MR by AngII in human SMCs 11 , we examined the effects of in vivo AngII infusion on blood pressure responses in SMC-MR deficient mice. As expected 27 , AngII infusion produced a robust hypertensive response in Cre − mice that was significantly enhanced in aged compared to adult mice (Fig. 4a,b) . In adult Cre + mice, the maximal pressor response to AngII was reduced by 31%, correlating with a 44% reduction in maximal contraction of MRAs in response to AngII (Fig. 4a,c) . In aged Cre + mice, there was no significant AngII pressor response, correlating with a lack of significant contraction in response to AngII in MRAs from aged Cre + mice (Fig. 4b,d) .
The pressor response to AngII involves production of reactive oxygen species (ROS) 28 , as confirmed by inhibition of the AngII pressor response in adult and aged mice by treatment with the SODmimetic TEMPOL (Supplementary Fig. 5 ). We quantified basal and AngII-stimulated vascular ROS production by whole-vessel dihydroethidium staining of carotid arteries. In adult mice, there was no difference in basal vascular ROS production between Cre − and Cre + mice, but AngII-stimulated ROS production was attenuated in Cre + compared to Cre − mice (Fig. 4e) . These findings are consistent with a lack of difference in basal blood pressure in adult Cre − and Cre + mice and with attenuation of the AngII pressor response in Cre + mice. In aged mice, basal vascular ROS production was significantly decreased in vessels from Cre + compared to Cre − mice, and ROS production in Cre + vessels did not increase in response to AngII (Fig. 4f) . These results also correlate with the decreased basal blood pressure and loss of AngII pressor and contractile responses in aged Cre + mice. These data support the concept that SMC-MR contributes substantially to AngII-induced vascular oxidative stress, vascular constriction and blood pressure elevation, particularly in the aging vasculature, and show that the previously described bidirectional crosstalk between MR and AT1R signaling in SMCs 11, 29 has in vivo relevance.
Together, these studies demonstrate that SMC-MR modulates vascular contractile function and tone independently of changes in vascular structure or defects in renal sodium handling, contributing to the blood pressure response to AngII and the age-associated increase in blood pressure. These findings support the emerging hypothesis that direct regulation of vascular tone contributes to the regulation of systemic blood pressure 30 and are consistent with clinical studies suggesting extrarenal mechanisms underlying the development of hypertension and associated cardiovascular diseases 8, 9 . These studies also support the concept that effects on vascular MR contribute to the electrolyte-independent antihypertensive effects of AT1R-and MR-antagonist drugs 6, 20 . Notably, modulation of renal vascular tone could alter renal function, as new treatments for hypertension are targeting renal vascular sympathetic tone with some success 31 . Thus, although renal MR function was not affected in mice with SMC-MR deficiency, regulation of renal vascular tone by SMC-MR could have secondary effects on sodium handling that could also affect blood pressure control.
Vessels from aged SMC-MR-deficient mice had profoundly reduced myogenic tone and contraction to the G protein-coupled receptor (GPCR) agonists thromboxane and AngII (but not to the GPCR agonist phenylephrine, which can act through divergent signaling mechanisms). Thromboxane receptor antagonism inhibits AngIIinduced hypertension 32 , supporting the idea that there is an overlap between the AT1R and thromboxane receptor signaling pathways that involves SMC-MR. Both pathways modulate Ca channel activity 22,33 , npg which was reduced in aged SMC-MR deficient mice. Angiotensinmediated ROS production has been shown to regulate vascular Cav1.2 expression 34 , suggesting a potential mechanistic link between reduced vascular ROS and Cav1.2 expression in these mice. Further exploration of the role of SMC-MR in the regulation of vascular GPCR signaling, Ca channel expression and oxidative stress is warranted.
Aging-associated hypertension is common, with an incidence approaching 80% in individuals over 80 years of age 1 . Although there is potential for some adaptive benefit to the rise in blood pressure with age, this phenomenon contributes substantially to the incidence of heart attack, stroke, atrial fibrillation and kidney and heart failure in the aging population worldwide 1, 2 . Deficiency in SMC-MR prevented many aspects of cardiovascular aging in our mouse model, including increased blood pressure, cardiac hypertrophy, vascular contraction, blood pressure responsiveness to AngII and oxidative stress, supporting a role of SMC-MR as a global regulator of vascular aging. Currently used MR antagonists have beneficial effects on blood pressure and mortality in people with cardiovascular disease, but hyperkalemia mediated by renal MR inhibition is a major limitation to their clinical use. Further study of the diverse roles of the MR and the signaling pathways it regulates in the vasculature may lead to the development of new therapies for common cardiovascular disorders, particularly in the aging population.
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